Cannabis stocks saw a short-lived rally Tuesday following reports that the DEA will move to reschedule marijuana from a Schedule I to a Schedule III substance. The DEA's proposal would recognize the medical uses of cannabis and acknowledge it has less potential for abuse than Schedule I substances.
Cannabis stocks soared Tuesday following reports that the DEA will move to reschedule marijuana from a Schedule I to a Schedule III substance. IM Cannabis shares are holding the gains, while larger weed stocks including Canopy Growth Corporation, Aurora Cannabis, Inc. and Tilray Brands, Inc. are dropping Wednesday.
CytomX Therapeutics shares are racing higher Wednesday. The company said it will report first-quarter results and provide an initial CX-904 Phase 1a dose escalation update on May 8, after the close of markets.
Super Micro Computer reported quarterly earnings of $6.65 per share which beat the analyst consensus estimate of $5.78 by 15.05% and represents a 307.98% increase over earnings of $1.63 per share from the same period last year. Quarterly sales clocked in at $3.85 billion which missed the analyst consensus estimate of $3.952 billion by 2.58% and is a 200.08% increase year-over-year.
A former employee reportedly provided prosecutors from the Southern District of New York with documents showing CashApp required insufficient information related to customer risk-assessment, Square processed thousands of transactions involving countries subject to economic sanctions and Block processed cryptocurrency transactions for terrorist groups.
Pacific Gas & Electric is reportedly nearing a deal to sell a stake in its fleet of power plants to KKR & Co. in an effort to raise funds needed to upgrade infrastructure and reduce the risk of fire resulting from its power lines.